Medical Charities Desert Mar-a-Lago

Breast cancer organization Susan G. Komen is the seventh organization this week to cancel plans to use the venue for fundraising events.

Written byCatherine Offord
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share


WIKIMEDIA, LIBRARY OF CONGRESS, PRINTS AND PHOTOGRAPHS DIVISION, FL-195-5

Four major organizations have today (August 18) cancelled plans to hold large fundraising events at Donald Trump’s Mar-a-Lago Club, adding to snowballing fallout from the president’s controversial comments about events in Charlottesville, Virginia, over the weekend. The organizations, which include the American Red Cross and breast cancer organization Susan G. Komen, join three others that made similar moves to distance themselves from Trump’s Palm Beach resort earlier this week.

“Our values and commitment to diversity are critical as we work to address the impact of cancer in every community,” American Cancer Society spokeswoman Miriam Falco said in statement on Thursday, as the organization announced its decision to find an alternative venue for its 2018 annual fundraiser, the Associated Press reports. “It has become increasingly clear ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • After undergraduate research with spiders at the University of Oxford and graduate research with ants at Princeton University, Catherine left arthropods and academia to become a science journalist. She has worked in various guises at The Scientist since 2016. As Senior Editor, she wrote articles for the online and print publications, and edited the magazine’s Notebook, Careers, and Bio Business sections. She reports on subjects ranging from cellular and molecular biology to research misconduct and science policy. Find more of her work at her website.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies